Xifaxan 550 MG tablet 60S
Ended Awarded Last action
- Contract number
- SPE2DR26F3UBH
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $18,334
Award facts
- Contract value 100% obligated
- $18,333.90 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to Amerisourcebergen Drug Corp (a subsidiary of Cencora, Inc.) on January 21, 2026, for the supply of Xifaxan 550 mg tablets in a 60-count package format. The contract, with a ceiling value of $18,333.90 and firm fixed-price terms, represents a non-set-aside competitive award with an ultimate completion date of January 22, 2026. The awardee will perform fulfillment operations from its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under Amerisourcebergen's broader Indefinite Delivery Contract with DLA Troop Support Medical, a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 through December 2026 that enables the company to supply a wide range of pharmaceuticals and medical supplies to support military healthcare programs worldwide.
Amerisourcebergen Drug Corp serves as a critical vendor in the federal pharmaceutical supply chain, with an extensive portfolio of medical product deliveries predominantly through the Defense Logistics Agency and its Medical Supply Chain. The company's federal contracting demonstrates versatility in fulfilling government medical supply needs across multiple therapeutic domains, with delivery orders structured as firm fixed-price arrangements ranging from nominal to substantial values. This award reflects the company's ongoing capability to meet competitive procurement requirements for pharmaceutical products supporting military healthcare systems, veterans' healthcare programs, and other federal medical institutions.
Quick answers
Who was awarded contract SPE2DR26F3UBH?
SPE2DR26F3UBH was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 21, 2026.
How much is contract SPE2DR26F3UBH worth?
The government has obligated $18,334 on SPE2DR26F3UBH.
Is contract SPE2DR26F3UBH an order under another contract?
Yes. SPE2DR26F3UBH is a delivery order under SPE2DR25D2104, an indefinite delivery contract.
Was contract SPE2DR26F3UBH competed?
The extent of competition for SPE2DR26F3UBH was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award